There are 702 resources available
498TiP - Adjuvant trastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical surg
Presenter: Vincenzo Nasca
Session: Poster Display session
499TiP - A single arm phase II trial of trastuzumab deruxtecan in patients with gastro-oesophageal adenocarcinoma cancer who are ctDNA and HER2 positive: DECIPHER (TRIALS IN PROGRESS)
Presenter: Elizabeth Smyth
Session: Poster Display session
500TiP - An open label phase Ib/II study of trastuzumab deruxtecan (T-DXd) in combination with nivolumab and CAPOX for patients with HER2-low expressing gastroesophageal adenocarcinoma (EPOC2203)
Presenter: Yu Aoki
Session: Poster Display session
501TiP - Valemetostat and trastuzumab deruxtecan (T-DXd) in previously treated advanced or metastatic human epidermal growth factor receptor 2 (HER2)-positive gastric or gastro-esophageal junction (GEJ) adenocarcinoma
Presenter: Kohei Shitara
Session: Poster Display session
502TiP - Design and rationale of the PROSPECTive evaluation of nivolumab in adjuvant esophageal cancer/gastroesophageal junction cancer (EC/GEJC) (PROSPECT-ESO): A prospective, non-interventional, multicentre cohort study
Presenter: Manish Shah, Anwaar Saeed
Session: Poster Display session
503P - Effect of probiotics on gut microbiota diversity during chemotherapy treatment in patients with gastrointestinal cancer
Presenter: Nora Forones
Session: Poster Display session
505P - State of the art of gastrointestinal (GI) cancer trials for older patients (pts): A systematic review (SR)
Presenter: Roberta Fazio
Session: Poster Display session
506P - Consensus guidance for management of nausea/vomiting in patients treated with zolbetuximab + chemotherapy: A RAND/UCLA modified Delphi panel study
Presenter: Samuel Klempner
Session: Poster Display session
507P - Oncology biomarker recommendations for gastrointestinal cancers as part of ONCOMARKR: The oncology biomarker review project
Presenter: Jennifer Hinkel
Session: Poster Display session
508P - Efficacy and safety of transradial versus transfemoral access during transarterial radioembolization in liver tumors: A systematic review and meta-analysis
Presenter: Hatem Eldeeb
Session: Poster Display session